MA
ALXA

MUFG Americas’s Alexza Pharmaceuticals Inc ALXA Stock Holding History

MUFG Americas’s Portfolio ALXA Stock Details ALXA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-800
Closed -$1K – 1303
2015
Q3 		$1K Sell
800
-3,840
-83% -$4.49K ﹤0.01% 1159
2015
Q2 		$5K Hold
4,640
– – ﹤0.01% 988
2015
Q1 		$10K Buy
4,640
+970
+26% +$1.99K ﹤0.01% 928
2014
Q4 		$5K Buy
3,670
+1,450
+65% +$2.59K ﹤0.01% 1099
2014
Q3 		$5K Buy
+2,220
New +$8.47K ﹤0.01% 1108

Other funds holding ALXA

LPA
Lansdowne Partners Austria Vienna, Austria $29M AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CLOS
Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland $9.25B AUM 27.04% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

MUFG Americas's ALXA Position: Q4 2015 in Review

MUFG Americas sold out of Alexza Pharmaceuticals Inc (ALXA) in Q4 2015, closing a stake of 800 shares — an estimated $1K sold.

MUFG Americas first reported a position in ALXA in Q3 2014 and held it in 5 quarters. The position peaked at $10K in Q1 2015. 26 funds tracked by Wall St. Rank hold ALXA as of Q4 2015.

  • MUFG Americas reported no remaining Alexza Pharmaceuticals Inc position as of Q4 2015 after selling out during the quarter.
  • MUFG Americas sold 800 Alexza Pharmaceuticals Inc shares in Q4 2015, an estimated $1K.
  • MUFG Americas first reported a position in Alexza Pharmaceuticals Inc in Q3 2014 and held it in 5 quarters.
  • MUFG Americas's Alexza Pharmaceuticals Inc position peaked at $10K in Q1 2015.
  • 26 funds tracked by Wall St. Rank held Alexza Pharmaceuticals Inc as of Q4 2015.

Based on MUFG Americas's 13F filing for Q4 2015, filed 10 Feb 2016.